Teva Pharmaceutical
Antifragility and Value Investing – Part 2
In addition to our traditional quality analysis, which falls into three buckets (business, balance sheet, and management), we also look at companies through the slightly different lens of fragility.
Antifragility and Value Investing – Part 1
What do you do when a company you own makes a large acquisition?
These Clues Tell You If A Company Is Making A Dumb Acquisition
As a shareholder, you do well to place more emphasis on risk than on reward. Corporate management usually does the opposite, and this is why most large acquisitions fail.
Purchase of Allergan and Sale of Teva
June 22, 2016 – Excerpt from Q2 2016 letter to IMA’s clients To talk about our purchase of Allergan we ...
